Welcome to LookChem.com Sign In|Join Free

CAS

  • or

135943-41-8

Post Buying Request

135943-41-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

135943-41-8 Usage

General Description

1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone is a chemical compound with the molecular formula C16H15NO2. It is a substituted pyridine derivative that contains a methoxyphenyl group and an ethanone functional group. 1-(5-(4-methoxyphenyl)pyridin-2-yl)ethanone exhibits potential pharmacological properties and has been studied for its potential use in the treatment of various diseases. Its structure and properties make it a potential candidate for drug development and further research in the field of medicinal chemistry. The compound's specific activities and potential applications may vary depending on the methods of synthesis and purification, as well as the specific form and concentration in which it is used.

Check Digit Verification of cas no

The CAS Registry Mumber 135943-41-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,9,4 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135943-41:
(8*1)+(7*3)+(6*5)+(5*9)+(4*4)+(3*3)+(2*4)+(1*1)=138
138 % 10 = 8
So 135943-41-8 is a valid CAS Registry Number.

135943-41-8Relevant articles and documents

A general Suzuki cross-coupling reaction of heteroaromatics catalyzed by nanopalladium on amino-functionalized siliceous mesocellular foam

Bratt, Emma,Verho, Oscar,Johansson, Magnus J,Baeckvall, Jan-Erling

, p. 3946 - 3954 (2014/05/20)

Suzuki-Miyaura cross-coupling reactions of heteroaromatics catalyzed by palladium supported in the cavities of amino-functionalized siliceous mesocellular foam are presented. The nanopalladium catalyst effectively couples not only heteroaryl halides with

PYRIDINE DERIVATIVES

-

Page/Page column 49; 50, (2013/04/13)

The present application provides novel pyridine compounds and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP 17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CPY17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer.

Synthetic routes for a new family of chiral tetradentate ligands containing pyridine rings

Dueggeli, Matias,Goujon-Ginglinger, Catherine,Ducotterd, Sarah Richard,Mauron, David,Bonte, Christophe,Von Zelewsky, Alexander,Stoeckli-Evans, Helen,Neels, Antonia

, p. 1894 - 1899 (2007/10/03)

A series of new tetradentate ligands containing two bipyridine groups or two pyridine moieties carrying amine substituents has been synthesised either from 5′- and 6′-substituted chiral bipyridines, or from chiral pyridine derivatives. These precursors ha

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 135943-41-8